Put two packs of CBD seeds next to each other, one marked 1:1 and the other 20:1, and they look the same: the same brand packaging, the same seed count, seeds which no eye can separate apart. Grow them side by side and they part ways from the very first stage and do not meet again. The cause is a single gene, and the easiest way to see what it does is to follow the two packs along each stage both share: the cross that made them, the seed, the seedling, the flower room, the cut, the jar, the lab bench and the law. The lines quoted as examples below are drawn from the range at https://calmcbdseeds.com, which runs 1:1, 2:1 and 20:1 with a top line at around 30 to one; the genetics holds the same regardless of which shop the seeds come from.
Stage One: At the Breeder’s Bench
Cannabis decides if it is going to produce THC or CBD at one position on the genome. The gene there comes in two forms: one builds the enzyme that turns the common precursor into THCA, the other the enzyme that converts it into CBDA. Every plant carries two copies, one received from either parent, and the combination fixes the chemotype. Two THC copies give a THC-dominant plant. Two CBD copies give a CBD-dominant one. One of each gives a balanced plant, since the two forms are codominant and neither overrides the other.
The 1:1 pack was bred by pairing two balanced plants, each carrying one copy of each form. The 20:1 pack was bred by pairing two plants which each hold two CBD copies and no THC copy in either of them. That one difference at the bench determines all that follows downstream, and the difference is already in the seed long before it is put in the foil.
Stage Two: Inside the Seed
Cross two balanced plants and the seeds sort out by the simplest rule in genetics: a quarter get two THC copies, a quarter get two CBD copies, half inherit one of each. In a pack of 10 seeds that works out to, on average, around two THC-dominant seeds, around two CBD-dominant ones, and five true balanced seeds. The pack is labelled by its parents, and in the case of half its seeds the label is accurate; in the case of the other half it is a description of something else. Calm CBD Seeds prints the expected split on every balanced line, so the buyer sees ahead of planting that a share of the plants are going to differ from the stated ratio.
The 20:1 pack carries no such split. Each seed received a CBD copy from both parents, each plant will be CBD-dominant, and the ratio on the foil holds to all of them, give or take the ordinary differences in how much total cannabinoid any individual plant builds. Breeders say such lines “breed true” for chemotype; the term refers to precisely this lack of surprise.
Weeks One to Four
Here the two packs look the same again, and the resemblance holds longer than many growers expect. Chemotype leaves no trace on a seedling. Leaf shape, vigour, internode spacing and growth rate are governed by different genes altogether, and the different kinds of plant in the 1:1 pack grow indistinguishably from one another and from each plant in the 20:1 pack.
One practical distinction at this stage arises from ancestry rather than chemotype. Lines with recent hemp ancestry, and that includes some less developed CBD-dominant lines, are inclined to stretch taller and fill out more sparsely. A well-worked 20:1 strain behaves like any modern hybrid; a early-generation one may still carry the field in its frame. Not one of these habit tells a thing about the ratio to come.
When the Resin Comes In
In flower the two packs start to give hints, and the majority of them point the wrong way. Trichome density is the usual thing a grower judges, and it used to be a fair rule: early CBD-dominant lines carried visibly less frost than their THC cousins, an unwanted inheritance from hemp. Modern selections have mostly erased that gap, and a lightly frosted plant from the 20:1 pack can perfectly well come in exactly where the foil promised. Resin density and chemotype are inherited on separate genes.
Smell is an even poorer guide. The terpene profile sits on still other genes, so the THC-dominant plant sitting in the 1:1 pack can be indistinguishable to the balanced one beside it, and both can be identical to a plant from the 20:1 pack. Growers who try to sort a balanced pack by nose in week eight are guessing, which is no better than leaving the plants unsorted at all.
Stage Five: The Harvest Window
At this stage the two packs diverge in a way that favours the grower of the 20:1 pack and also the CBD-dominant plants hidden in the 1:1 pack. CBDA breaks down rather gradually than THCA, so a CBD-dominant plant allowed a week past its ideal point keeps the bulk of its cannabinoid load, where a THC-dominant one in the same conditions has by then started shedding THC to CBN. The usual trichome rules still applies; it holds on account of the terpenes, which fade on any plant regardless the chemotype, and a late, rushed CBD flower tastes of very little however good the lab result is.
Stage Six: The Jar
The 20:1 pack goes into one jar. Each plant in it carries roughly the same ratio, and blending them alters nothing anyone would measuring. The 1:1 pack should never be handled that way. Pool its 10 plants into a single jar and the result is a mixture that nobody’s foil ever promised, skewed by which plants grew most, and nothing on a later test can pull apart the plants that went in.
The discipline that saves the grief is dull: harvest the balanced pack plant by plant, cure every one apart, number each, and test them one at a time rather than after anything is mixed. It is the one stage in the entire process where the three chemotypes of plant in the 1:1 pack can still be kept apart without a laboratory, and then only for the reason that each is at that moment in its own container.
Stage Seven: The Lab Report
Submit a sample from each jar to a laboratory and the two packs finally are readable. For the 20:1 pack the certificates come back clustered tightly around the advertised ratio, varying mostly in total cannabinoid content rather than in balance. For the 1:1 pack they come back in three clusters: some reports showing almost all THC, a few showing nearly all CBD, and the rest somewhere near one to one. No part of this result is a failure; it is the bench cross expressed as numbers.
Over-the-counter test kits are sold for growers without a lab, and the majority of them detect whether THC is present but not how much. That is enough to pull the THC-dominant jars out from a balanced pack and not to assign a ratio to the others, which suits the commonest need: knowing which of the 10 jars will catch out someone.
Stage Eight: The Border
The last stage where the two packs separate is legal, and it catches growers who assumed “CBD” was shorthand for “hemp”. Most jurisdictions classify hemp by a THC limit, a fraction of a percent of dry weight, with the exact number varying from country and sometimes year to year. A plant from the 20:1 pack producing twenty percent CBD at twenty to one also makes about one percent THC, which is several times over the majority of thresholds. Certified hemp cultivars are selected to hold total cannabinoid output down so the THC share remains under the line right up to maturity; CBD flower lines are selected for high output and let the THC scale with it. A seller that gives only a ratio is selling a flower line; anyone who needs a compliant crop needs to look for a tested THC figure at maturity and order no line that does not provide one.
Beyond the threshold issue, the word on the foil changes nothing in the law on the seed itself. Where holding cannabis seeds is permitted and germinating them is not, the 1:1 pack and the 20:1 pack sit in the same position as any other pack. Where the plant is legal outright, the decision between them is a matter of preference and nobody else’s. None of this article is legal advice, and the rule that applies is the one in the place the seed will be sown, rather than the one where it was bought.